505 related articles for article (PubMed ID: 30450045)
1. Predicting Responses to Psychedelics: A Prospective Study.
Haijen ECHM; Kaelen M; Roseman L; Timmermann C; Kettner H; Russ S; Nutt D; Daws RE; Hampshire ADG; Lorenz R; Carhart-Harris RL
Front Pharmacol; 2018; 9():897. PubMed ID: 30450045
[TBL] [Abstract][Full Text] [Related]
2. Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
Roseman L; Haijen E; Idialu-Ikato K; Kaelen M; Watts R; Carhart-Harris R
J Psychopharmacol; 2019 Sep; 33(9):1076-1087. PubMed ID: 31294673
[TBL] [Abstract][Full Text] [Related]
3. Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.
Kuc J; Kettner H; Rosas F; Erritzoe D; Haijen E; Kaelen M; Nutt D; Carhart-Harris RL
Psychopharmacology (Berl); 2022 May; 239(5):1425-1440. PubMed ID: 34734314
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.
Nygart VA; Pommerencke LM; Haijen E; Kettner H; Kaelen M; Mortensen EL; Nutt DJ; Carhart-Harris RL; Erritzoe D
J Psychopharmacol; 2022 Aug; 36(8):932-942. PubMed ID: 35924888
[TBL] [Abstract][Full Text] [Related]
5. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.
Roseman L; Nutt DJ; Carhart-Harris RL
Front Pharmacol; 2017; 8():974. PubMed ID: 29387009
[No Abstract] [Full Text] [Related]
6. Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness.
Kettner H; Rosas FE; Timmermann C; Kärtner L; Carhart-Harris RL; Roseman L
Front Pharmacol; 2021; 12():623985. PubMed ID: 33995022
[No Abstract] [Full Text] [Related]
7. Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports.
Žuljević MF; Mijatović A; Marušić SL; Kudrjavets G; Buljan I; Hren D
J Psychoactive Drugs; 2023 Nov; ():1-13. PubMed ID: 37921118
[TBL] [Abstract][Full Text] [Related]
8. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
Nour MM; Evans L; Nutt D; Carhart-Harris RL
Front Hum Neurosci; 2016; 10():269. PubMed ID: 27378878
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.
Barrett FS; Robbins H; Smooke D; Brown JL; Griffiths RR
Front Psychol; 2017; 8():1238. PubMed ID: 28790944
[TBL] [Abstract][Full Text] [Related]
10. The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.
Sweat NW; Bates LW; Hendricks PS
J Psychoactive Drugs; 2016; 48(5):344-350. PubMed ID: 27719438
[TBL] [Abstract][Full Text] [Related]
11. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
[TBL] [Abstract][Full Text] [Related]
12. Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.
Barbut Siva J; Barba T; Kettner H; Kuc J; Nutt DJ; Carhart-Harris R; Erritzoe D
J Psychopharmacol; 2024 Feb; 38(2):145-155. PubMed ID: 38281075
[TBL] [Abstract][Full Text] [Related]
13. Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
Kangaslampi S; Hausen A; Rauteenmaa T
J Psychoactive Drugs; 2020; 52(4):309-318. PubMed ID: 32511073
[TBL] [Abstract][Full Text] [Related]
14. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.
Davis AK; Barrett FS; Griffiths RR
J Contextual Behav Sci; 2020 Jan; 15():39-45. PubMed ID: 32864325
[TBL] [Abstract][Full Text] [Related]
15. Psychedelics and hypnosis: Commonalities and therapeutic implications.
Lemercier CE; Terhune DB
J Psychopharmacol; 2018 Jul; 32(7):732-740. PubMed ID: 29938563
[TBL] [Abstract][Full Text] [Related]
16. The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity.
Hartogsohn I
Front Neurosci; 2018; 12():129. PubMed ID: 29559884
[TBL] [Abstract][Full Text] [Related]
17. Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing.
Qiu TT; Minda JP
J Psychoactive Drugs; 2023; 55(2):123-133. PubMed ID: 35438609
[TBL] [Abstract][Full Text] [Related]
18. Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.
Mosurinjohn S; Roseman L; Girn M
Front Psychiatry; 2023; 14():1077311. PubMed ID: 37181886
[TBL] [Abstract][Full Text] [Related]
19. The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.
Winkelman MJ
Front Pharmacol; 2021; 12():619890. PubMed ID: 33732156
[TBL] [Abstract][Full Text] [Related]
20. Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use.
Hübner S; Haijen E; Kaelen M; Carhart-Harris RL; Kettner H
J Med Internet Res; 2021 Jul; 23(7):e25973. PubMed ID: 34319246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
